In this non-comparative , open-label , randomised phase @ trial , we recruited patients with locally advanced ( non-resectable ) or metastatic cholangiocarcinoma , gallbladder carcinoma , or ampullary carcinoma and a WHO performance status of @ or @ from @ hospitals across France and Germany .